NeoNotes Home | Index | Search | Submit Article Summary | Email the Editor | FSN Home Page
| Ref # | Topic | Date Reviewed | Reviewer | Additional Comments |
|---|---|---|---|---|
| 1-043 | Dec 2000 | Griffith E. Quniby MD | 1 | |
| 1-042 | Indomethacin Prophylaxis in Preterm Infants | Dec 2000 | Griffith E. Quniby MD | 0 |
| 1-041 | Dec 2000 | Griffith E. Quniby MD | 0 | |
| 1-040 | Prone Sleeping and SIDS | Dec 2000 | Andrew B. Kairalla MD | 0 |
| 1-039 | Baby CareLink | Dec 2000 | Andrew B. Kairalla MD | 0 |
| 1-038 | Folic Acid Antagonists | Dec 2000 | Andrew B. Kairalla MD | 0 |
| 1-037 | Intraraptum Fever and Seizures | Dec 2000 | Andrew B. Kairalla MD | 0 |
| 1-036 | Surfactant and GBS Infection | Dec 2000 | Andrew B. Kairalla MD | 0 |
| 1-035 | Nov 2000 | Andrew B. Kairalla MD | 0 | |
| 1-034 | Nov 2000 | Andrew B. Kairalla MD | 1 | |
| 1-033 | Nov 2000 | Andrew B. Kairalla MD | 0 | |
| 1-032 | Nov 2000 | Andrew B. Kairalla MD | 0 | |
| 1-031 | Nov 2000 | Andrew B. Kairalla MD | 0 | |
| 1-030 | Gestational Age Terminology | Nov 2000 | Andrew B. Kairalla MD | 0 |
| 1-029 | Treatment of Neonatal Pneumonia | Nov 2000 | Andrew B. Kairalla MD | 1 |
| 1-028 | Iron Supplementation | Nov 2000 | Andrew B. Kairalla MD | 0 |
| 1-027 | Hypothermia for Neonatal HIE | Oct 2000 | Andrew B. Kairalla MD | 0 |
| 1-026 | ELBW Outcomes to Discharge | Oct 2000 | Andrew B. Kairalla MD | 0 |
| 1-025 | Outcomes at 20-25 weeks gestation | Sept 2000 | Andrew B. Kairalla MD | 0 |
| 1-024 | Delayed Cord Clamping | Sept 2000 | Andrew B. Kairalla MD | 1 |
| 1-023 | Click Test for RDS | Sept 2000 | Andrew B. Kairalla MD | 0 |
| 1-022 | Surgery for Brachial Plexus Injuries | Sept 2000 | Andrew B. Kairalla MD | 0 |
| 1-021 | Risk Factors for CLD | July 2000 | Andrew B. Kairalla MD | 0 |
| 1-020 | Neurodevelopmental Outcomes | July 2000 | Andrew B. Kairalla MD | 0 |
| 1-019 | Skin Care and Candidiasis | July 2000 | Andrew B. Kairalla MD | 0 |
| 1-018 | Ibuprofen for PDA | July 2000 | Andrew B. Kairalla MD | 0 |
| 1-017 | Hip Dysplasia Screening | April 2000 | Andrew B. Kairalla MD | 0 |
| 1-016 | Supine Positioning | April 2000 | Andrew B. Kairalla MD | 0 |
| 1-015 | Spironolactone for CLD | April 2000 | Andrew B. Kairalla MD | 0 |
| 1-014 | Nitric Oxide for PPHN | April 2000 | Andrew B. Kairalla MD | 0 |
| 1-013 | Pulmonary Deadspace Determinations | April 2000 | Andrew B. Kairalla MD | 0 |
| 1-012 | PDE-5 inhibitor treats PPHN | April 2000 | Andrew B. Kairalla MD | 0 |
| 1-011 | Antenatal Lung Volume Assessment | April 2000 | Andrew B. Kairalla MD | 0 |
| 1-010 | Lower Frequencies on HFOV | April 2000 | Andrew B. Kairalla MD | 0 |
| 1-009 | Tidal Volumes on HFOV | April 2000 | Andrew B. Kairalla MD | 0 |
| 1-008 | Relative Benefit of HFOV vs CV | April 2000 | Andrew B. Kairalla MD | 0 |
| 1-007 | Survival in Infants < 500 Grams | April 2000 | Andrew B. Kairalla MD | 0 |
| 1-006 | Long Term Outcome after HFOV | April 2000 | Andrew B. Kairalla MD | 0 |
| 1-005 | Early High Frequency Ventilation | April 2000 | Andrew B. Kairalla MD | 0 |
| 1-004 | Prophylactic vs Rescue Surfactant | April 2000 | Andrew B. Kairalla MD | 0 |
| 1-003 | Maternal Fever/ Neonatal Outcome | January 2000 | Andrew B. Kairalla MD | 0 |
| 1-002 | Early Postnatal Steroids | January 2000 | Andrew B. Kairalla MD | 0 |
| 1-001 | Early-onset Neonatal Sepsis | January 2000 | Andrew B. Kairalla MD | 0 |